Accessibility settings

This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (5152) Serious Games for Health and Medicine (1208) Usability of Apps and User Perceptions of mHealth (1802) Design and Formative Evaluation of Mobile Apps (1011) mHealth for Patient Education (419) mHealth in Medical Education and Training (221) Precision Medicine (437)

Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56553, first published .
Student assembling molecular model near laptop displaying DNA helix

An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study

An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study

Authors of this article:

Carlos Marras1 Author Orcid Image ;   María Labarga2 Author Orcid Image ;   Daniel Ginard3 Author Orcid Image ;   Jose Manuel Carrascosa4 Author Orcid Image ;   Alejandro Escudero-Contreras5 Author Orcid Image ;   Eduardo Collantes-Estevez5 Author Orcid Image ;   Fernando de Mora6 Author Orcid Image ;   Tamara Robles2 Author Orcid Image ;   Elisa Romero2 Author Orcid Image ;   Rafael Martínez2 Author Orcid Image
Article Authors Cited by (6) Tweetations (7) Metrics

Journals

  1. Al Meslamani A, Jarab A, Mohammed E, Elrefae A. Biosimilar stewardship at the interface of disproportionality methods and AI integration: current evidence and potential strategies. Expert Opinion on Biological Therapy 2026;26(2):157 View
  2. Domínguez-Fernández S, Montenegro-Méndez S, González-Rodríguez M, Cano-Sanz N, Duro-Martínez A, Bella-Castillo P, Fontán-Vinagre G, Guerrero-Menéndez R. Assessing Nurses’ Knowledge and Attitudes Towards Biosimilars: Results from a National Survey. Healthcare 2026;14(4):524 View
  3. Duwez M, Finckh A, Bonnabry P. A pharmacist-led intervention to promote the uptake of an infliximab biosimilar by patients and physicians in a university hospital rheumatology unit. European Journal of Hospital Pharmacy 2026;33(5):423 View
  4. Basem Y, Ata A, Sabry F, Mohammed D, Ashraf M, Abdelmonem R, Bakr A. The Future of Biopharmaceutical Industry: Innovations, Challenges, and Implications for Global Health Systems. International Journal of Clinical Medical Research 2026;4(3):161 View
  5. Nguyen C, Dang L. Biosimilars in inflammatory bowel disease: Beyond evidence, toward trust and implementation. World Journal of Gastroenterology 2026;32(28) View
  6. Al Meslamani A, Jarab A, El Sharu H, Al Marshoodi K. Beyond the first switch: multiple switching, cross-switching, and nocebo-aware implementation of biosimilars in real-world care in non-US health systems. Expert Opinion on Biological Therapy 2026:1 View